The Patient Safety Company joins forces with software company symplr


Friday the 14th of February – Cloud-based healthcare software company The Patient Safety Company (TPSC) will form a strategic combination with symplr, a leading U.S. healthcare governance, risk and compliance (“GRC”) software-as-a-service (“SaaS”) platform. symplr is backed by Clearlake Capital Group, (together with its affiliates, “Clearlake”) and SkyKnight Capital (together with its affiliates, “SkyKnight”). TPSC was backed by Main Capital.
TPSC is based in Alkmaar, The Netherlands and provides quality and risk management software focused on patient safety to more than 250 healthcare institutions worldwide, such as hospitals, mental health departments, and ambulatory care institutions. In addition to strong local customers such as Academic Medical Center Amsterdam and UMC Utrecht, the company sells its software through a growing international partner network in 19 countries with North America and Australia being its largest international markets.

The strategic combination strengthens symplr’s platform, adding TPSC’s complementary patient safety and incident management, quality improvement, and credentialing solutions. TPSC’s flexible, multi-tenant cloud platform enables healthcare providers to easily configure their implementation without any programming knowledge. This flexibility is indispensable during times of budget challenges and increasing regulatory pressure.

“We are very enthusiastic about the synergy with symplr and share their ambition to become the world’s leading healthcare governance, risk and compliance software platform,” said Rick Bergen, CEO, The Patient Safety Company. “We are very excited to join the symplr family.”

“TPSC already has many successful US customers such as Vein Clinics (with 80 locations being the largest US network of vein treatment centers) and IntegraMed (large network of Fertility centers). With this strategic combination, we believe that both companies can accelerate each other’s international expansion“ Pieter van Bodegraven, Partner at Main Capital.

About The Patient Safety Company
The Patient Safety Company (TPSC) provides Governance, Risk & Compliance solutions, centered around the improvement of patient safety, to healthcare organisations such as hospitals, mental care institutions and outpatient care services. By means of the innovative TPSC Cloud™ platform, healthcare organisations can automate and support processes such as incident management, quality-/improvement management, and accreditation. The platform enables users to configure their own solutions without any programming knowledge. For more information visit

About Main Capital Partners
Main Capital Partners is a strategic investor with an exclusive focus on the software sector in the Benelux, DACH and Nordics regions. Main has a long-term investment horizon centered around successful partnerships with management teams, with the goal to, jointly, build larger software groups. Main has approximately € 1 billion in assets under management for investments in mature and growing software companies.

The current portfolio of Main Capital Partners includes rapidly growing software- and SaaS software companies like Optimizers, Assessio, GBtec, Onventis, HYPE Innovation, cleversoft, Enovation, SDB Groep, Jobrouter, GOconnectIT, Verklizan, Inergy, MUIS Software, Artegic, OBI4wan, b+m Informatik, Onguard, ChainPoint and RVC. Successful former companies that have grown substantially under the guidance of Main are;  Connexys (HR software), Roxit (governmental software), Axxerion (facility management software) and Ymor (APM software).

For more information please contact:
Pieter van Bodegraven
Main Capital Partners B.V., Paleisstraat 6, 2514 JA, Den Haag
Tel: +31(0)70-324 3433

Similar articles

The importance of branding for software companies – Newsletter July2021


Fenne Bijl
Read more

Main Capital backs Swedish financial software player Björn Lundén


Fenne Bijl
Read more

cleversoft group and CDDS Join Forces with the Support of Main Capital


Fenne Bijl
Read more

Houd mij op de hoogte

Meld u aan voor onze nieuwsbrief of volg ons op social media

reCAPTCHA is required.